EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-term persistence of baricitinib in alopecia areata: a real-world pharmacy-based cohort study

Roberto Daza-García iD, Alonso García-Núñez iD, Antonio Alcalá Ramírez Del Puerto iD, José Juan Pereyra-Rodríguez iD, Román Barabash-Neila iD

Clinical and Experimental Dermatology · 2026

DOI: 10.1093/ced/llag224 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Roberto Daza-García und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Virgen del Rocío, UGC Dermatología Médico-Quirúrgica y Venereología, Seville, Spain. Hauptthemen laut MEDLINE: Azetidines, Pyrazoles, Alopecia Areata, Sulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term baricitinib persistence in alopecia areata is not well defined. We performed a retrospective cohort study using hospital-pharmacy dispensing data from 77 patients. Discontinuation was defined as a gap of more than 90 days without medication coverage. The baseline Severity of Alopecia Tool (SALT) score was available for 75 of 77 patients; follow-up SALT data were incomplete. Overall Kaplan–Meier persistence was 91.3% [95% confidence interval (CI) 81.6–96.0] at week 52, 75.1% (95% CI 61.0–84.7) at week 104, and 68.7% (95% CI 52.8–80.2) at week 130. Week 130 persistence was lower in patients with baseline SALT ≥ 95 than in those with SALT < 95 (49.5% vs. 82.3%; exploratory log-rank P = 0.139). Chart-coded discontinuation reasons were heterogeneous and incomplete. Pharmacy-based persistence suggests durable real-world retention beyond 2 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzetidinesPyrazolesAlopecia AreataSulfonamidesPurinesDrug MonitoringHumansRetrospective StudiesFemaleMaleAdultMiddle AgedSeverity of Illness IndexKaplan-Meier Estimate

Substanzen

AzetidinesPyrazolesSulfonamidesbaricitinibPurines

Autor:innen und Institutionen

  • Hospital Universitario Virgen del Rocío, UGC Dermatología Médico-Quirúrgica y Venereología, Seville, Spain.

ORCID-Profile: Roberto Daza-García, Alonso García-Núñez, Antonio Alcalá Ramírez Del Puerto, José Juan Pereyra-Rodríguez, Román Barabash-Neila

Zitieren

APA

Daza-García, R., García-Núñez, A., Alcalá Ramírez Del Puerto, A., Pereyra-Rodríguez, J. J., & Barabash-Neila, R. (2026). Long-term persistence of baricitinib in alopecia areata: a real-world pharmacy-based cohort study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag224

Vancouver

Daza-García R, García-Núñez A, Alcalá Ramírez Del Puerto A, Pereyra-Rodríguez JJ, Barabash-Neila R. Long-term persistence of baricitinib in alopecia areata: a real-world pharmacy-based cohort study. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag224

BibTeX
@article{DazaGarca2026,
  author = {Daza-García, Roberto and García-Núñez, Alonso and Alcalá Ramírez Del Puerto, Antonio and Pereyra-Rodríguez, José Juan and Barabash-Neila, Román},
  title = {Long-term persistence of baricitinib in alopecia areata: a real-world pharmacy-based cohort study},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag224}
}
Kostenlos starten →